BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9266956)

  • 1. Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma.
    Probst-Kepper M; Schrader A; Buer J; Grosse J; Volkenandt M; Illiger HJ; Metzner B; Kadar J; Duensing S; Hertenstein B; Ganser A; Atzpodien J
    Br J Haematol; 1997 Aug; 98(2):488-90. PubMed ID: 9266956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells.
    Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Schenk F; Franzke A; Atzpodien J; Buer J
    Melanoma Res; 2000 Aug; 10(4):355-62. PubMed ID: 10985670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of leukaemic contamination in peripheral blood stem cell harvests by reverse transcriptase polymerase chain reaction.
    Nagafuji K; Harada M; Takamatsu Y; Eto T; Teshima T; Kamura T; Okamura T; Hayashi S; Akashi K; Murakawa M
    Br J Haematol; 1993 Nov; 85(3):578-83. PubMed ID: 7510991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
    Kunter U; Buer J; Probst M; Duensing S; Dallmann I; Grosse J; Kirchner H; Schluepen EM; Volkenandt M; Ganser A; Atzpodien J
    J Natl Cancer Inst; 1996 May; 88(9):590-4. PubMed ID: 8609659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma.
    Leung W; Chen AR; Klann RC; Moss TJ; Davis JM; Noga SJ; Cohen KJ; Friedman AD; Small D; Schwartz CL; Borowitz MJ; Wharam MD; Paidas CN; Long CA; Karandish S; McMannis JD; Kastan MB; Civin CI
    Bone Marrow Transplant; 1998 Nov; 22(10):971-9. PubMed ID: 9849694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukaemia.
    Miyamoto T; Nagafuji K; Harada M; Eto T; Fujisaki T; Kubota A; Akashi K; Mizuno S; Takenaka K; Kanaji T
    Br J Haematol; 1995 Sep; 91(1):132-8. PubMed ID: 7577620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy in patients with breast cancer: evaluation of infusing peripheral blood stem cells containing occult tumor cells.
    Weaver CH; Moss T; Schwartzberg LS; Zhen B; West J; Rhinehart S; Campos L; Beeker T; Lautersztain L; Messino M; Buckner CD
    Bone Marrow Transplant; 1998 Jun; 21(11):1117-24. PubMed ID: 9645574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of quantitative analysis of AML1/ETO transcripts in peripheral blood stem cells from t(8;21) acute myelogenous leukemia.
    Miyamoto T; Nagafuji K; Harada M; Niho Y
    Leuk Lymphoma; 1997 Mar; 25(1-2):69-75. PubMed ID: 9130615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of tyrosinase mRNA from the blood of melanoma patients.
    Stevens GL; Scheer WD; Levine EA
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction.
    Smith B; Selby P; Southgate J; Pittman K; Bradley C; Blair GE
    Lancet; 1991 Nov; 338(8777):1227-9. PubMed ID: 1719320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The differences between recombinant human granulocyte colony-stimulating factor-primed and non-primed peripheral blood stem cell harvests].
    Liang X; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2007 Jul; 46(7):566-8. PubMed ID: 17959081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood stem cell tumor cell contamination and survival of neuroblastoma patients.
    Corrias MV; Haupt R; Carlini B; Parodi S; Rivabella L; Garaventa A; Pistoia V; Dallorso S
    Clin Cancer Res; 2006 Oct; 12(19):5680-5. PubMed ID: 17020970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative immunomagnetic purging of peripheral blood stem cell harvests from breast carcinoma patients reduces tumor cell contamination while not affecting hematopoietic recovery.
    Pedrazzoli P; Lanza A; Battaglia M; Da Prada GA; Zambelli A; Perotti C; Ponchio L; Salvaneschi L; Robustelli della Cuna G
    Cancer; 2000 Jun; 88(12):2758-65. PubMed ID: 10870058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RT-PCR detection of tyrosinase, gp100, MART1/Melan-A, and TRP-2 gene transcripts in peripheral blood of melanoma patients.
    Samija M; Juretić A; Solarić M; Samija I; Bingulac-Popović J; Grahovac B; Stanec M; Oresić V
    Croat Med J; 2001 Aug; 42(4):478-83. PubMed ID: 11471202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumour.
    Vermeulen J; Ballet S; Oberlin O; Peter M; Pierron G; Longavenne E; Laurence V; Kanold J; Chastagner P; Lejars O; Blay JY; Marec-Berard P; Michon J; Delattre O; Schleiermacher G
    Br J Cancer; 2006 Nov; 95(10):1326-33. PubMed ID: 17088915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
    Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
    Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation.
    Hardingham JE; Kotasek D; Sage RE; Dobrovic A; Gooley T; Dale BM
    Bone Marrow Transplant; 1993 Jan; 11(1):15-20. PubMed ID: 8381694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method.
    de Vries TJ; Fourkour A; Punt CJ; Ruiter DJ; van Muijen GN
    Melanoma Res; 2000 Apr; 10(2):119-26. PubMed ID: 10803712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.